+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests

  • ID: 5315055
  • Report
  • March 2021
  • Region: Global
  • 312 Pages
  • Kalorama Information

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in the IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

The global volume of IVD procedures is forecast to increase 7.9% annually to 111.3 billion in 2025. The same timeframe will see worldwide sales of IVD products expanding 5.4% per year to $95 billion. Blood glucose monitoring activities will account for approximately 76% of testing volume and about $20 billion of product sales. Excluding blood glucose tests, global IVD procedural volume is forecast to rise 4.0% annually to 28.8 billion in 2025, with product sales increasing 5.3% annually to almost $76.5 billion.

The IVD landscape in 2020 has shifted due to the impact of the COVID-19 pandemic. The pandemic is impacting the world economy and creating uncertainty in the stock market and affecting supply chains all over the world.

IVD Test Procedure Volumes estimates IVD test procedure volume and IVD pricing for the following segments:

  • Worldwide IVD Market and Test Volume
  • Point-of-Care Market and Test Volume
  • Clinical Chemistry Market and Test Volume
  • Molecular Market and Test Volume
  • Hematology Market and Test Volume
  • Coagulation Market and Test Volume
  • Microbiology Market and Test Volume
  • COVID-19 Market and Test Volume
  • Blood Screening Market and Test Volume
  • Histology/Cytology Market and Test Volume
  • Immunoassay Market and Test Volume
  • IVD Testing Segments and Global IVD Markets

The range of IVD procedures includes point-of-care and laboratory tests that are categorized according to the testing technology employed. Approximately 20 different technologies have been adapted to IVD applications. The pursuit of needed improvements in healthcare resources and capabilities will boost growth opportunities for IVD procedures and products in the majority of developing countries. The report provides the following IVD testing data points:

  • Global IVD Procedure Volumes, 2019 and 2024
  • Global IVD Procedural Volume & Product Sales (excludes glucose tests), 2020-2025 (IVD Procedures [million], $ products/procedures, IVD Product Sales [$ millions])
  • IVD Procedural Volume including blood glucose tests (millions), 2020-2025 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
  • IVD Procedural Volume excluding blood glucose tests (millions), 2020-2025 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
  • IVD Product Sales including blood glucose tests ($ millions), 2020-2025 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
  • IVD Product Sales excluding blood glucose tests ($ millions), 2020-2025 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
  • IVD Procedural Volume excluding blood glucose tests by Region (millions), 2020-2025 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
  • IVD Product Sales excluding blood glucose tests by Region ($ millions), 2020-2025 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
  • Point-of-Care (POC) Procedures

Point-of-care (POC) testing encompasses diagnostic procedures performed in physicians’ offices, hospital rooms and departments (ICU, emergency, etc.), clinics, ambulances, nursing homes, pharmacies, private residences, and other venues where patients interact directly with medical professionals. This activity also includes the self-monitoring and self-detection of diseases, disorders, and other health conditions by individuals. Growth in the global volume of POC procedures will build upward momentum from several trends and factors. The report provides the following POC data points:

  • Total POC Procedural Volume & Product Sales including blood glucose tests, 2020-2025 (Self-Tests, Professional Tests)
  • Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2020-2025 (Self-Tests, Professional Tests)
  • POC Self-Test Procedural Volume by Type (millions), 2020-2025 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
  • POC Self-Test Product Sales by Type ($ millions), 2020-2025 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
  • POC Self-Test $ IVD Product Sales Per Procedure, 2020-2025 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Average, Average w/o glucose)
  • POC Professional Procedural Volume by Type (millions), 2020-2025 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
  • POC Professional IVD Product Sales by Type ($ millions), 2020-2025 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
  • POC Professional $ IVD Products Per Procedure by Type (millions), 2020-2025 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
  • Clinical Chemistry Procedures

Clinical chemistry enables the measurement of naturally produced and externally consumed compounds in the body. Increasing applications in basic physical examinations, routine patient check-ups, and the pre-admission and pre-discharge testing of hospital patients are predicted to boost the total global volume of laboratory clinical chemistry procedures. IVD Test Procedure Volumes provides the following data points with respect to clinical chemistry procedures:

  • Clinical Chemistry Procedural Volume by Type (millions), 2020-2025 (General Chemistry, Blood Gas Analysis, Urinalysis)
  • Clinical Chemistry Product Sales by Type ($ millions), 2020-2025 (General Chemistry, Blood Gas Analysis, Urinalysis)
  • Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2020-2025 (General Chemistry, Blood Gas Analysis, Urinalysis)
  • Molecular Testing Procedures

The science of molecular diagnostics compares DNA, RNA, genes, or proteins found in extracted human specimens to reference probes containing genetic matter linked to specific diseases, disorders or other medical conditions. Molecular assays continue to penetrate new and existing applications based on selectivity, sensitivity, speed, and accuracy advantages over alternative diagnostics. Molecular technologies will assume an increasingly important role in patient testing as breakthroughs in human genomic and proteomic fields are leading to the discovery of new genetic disease markers. The report provides the following molecular assay data points:

  • Molecular Assay Procedural Volume by Type (millions), 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
  • Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2020-2025 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
  • Molecular Assay Product Sales by Type ($ millions), 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
  • Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2020-2025 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
  • Molecular Assays $ Products per Procedure by Type, 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
  • Hematology Procedures

Hematology testing is widely implemented as part of basic patient examinations, pre-hospital admission screens, and initial emergency room evaluations. The report provides the following data points with respect to hematology procedures:

  • Hematology Procedural Volume by Type (millions), 2020-2025 (Complete Blood Count, Other Hematology Tests)
  • Hematology Product Sales by Type ($ millions), 2020-2025 (Complete Blood Count, Other Hematology Tests)
  • Hematology $ Product Sales Per Procedure by Type, 2020-2025 (Complete Blood Count, Other Hematology Tests)
  • Coagulation Testing Procedures

Coagulation tests diagnose and monitor various bleeding disorders and evaluate the effectiveness of blood-related therapies, notably anticoagulant agents such as heparin and warfarin, with increasing applications in surgical, inpatient, and emergency care underlying gains. The report provides the following coagulation testing data points:

  • Coagulation Procedural Volume (millions), 2020-2025
  • Coagulation Product Sales ($ millions), 2020-2025
  • Coagulation $ Products per Procedure, 2020-2025
  • Microbiology Procedures

Conventional microbiology testing is implemented globally to detect and analyze infectious diseases and related conditions. Spurred by upward trends in the incidence of infectious diseases, the global volume of conventional microbiology procedures is forecast to increase. IVD Test Procedure Volumes provides the following data points with respect to microbiology procedures:

  • Conventional Microbiology Procedural Volume by Type (millions), 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
  • Conventional Microbiology Product Sales by Type ($ millions), 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
  • Conventional Microbiology $ Product Sales Per Procedures by Type, 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
  • Blood Grouping/Typing Procedures

The blood banking segment applies IVD products to three major applications: the screening of donated blood for viral antigens, the matching of blood types between organ donors and recipients, and the identification of blood grouping and platelet antibodies. The report provides estimates of procedures, product sales, and prices appearing applying to blood grouping and typing functions only:

  • Blood Grouping/Matching Procedural Volume (millions), 2020-2025
  • Blood Grouping/Matching Product Sales ($ millions), 2020-2025
  • Blood Grouping/Matching $ Product Sales/Procedure, 2020-2025
  • Histology/Cytology Procedures

Histology and cytology are branches of clinical pathology that provide for the in vitro detection and analysis of various diseases and disorders. Histology procedures involve the examination of tissues, while cytology testing is performed on cells. Gains in these two disciplines reflect expanding use in cancer screening and diagnosis and, to a lesser extent, in the detection of infectious diseases and genetic disorders. The report provides the following histology/cytology data points:

  • Histology/Cytology Procedural Volume by Type (millions), 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
  • Histology/Cytology Product Sales by Type ($ millions), 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
  • Histology/Cytology $ Product Sales Per Procedure by Type, 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
  • Immunoassay Procedures

Immunoassays tests can be used to identify any medical condition that triggers an in vivo immune response, including cancer, cardiovascular damage, drug abuse, infectious and viral diseases, infertility, pregnancy, and thyroid disorders. They are also employed widely in therapeutic drug monitoring to evaluate the effectiveness of medicines against various tumors and pathogenic microorganisms. IVD Test Procedure Volumes provides the following data points with respect to immunoassay procedures:

  • Immunoassay Procedural Volume by Type (millions), 2020-2025 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
  • Immunoassay Product Sales by Type ($ millions), 2020-2025 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
  • Immunoassay $ Product Sales Per Procedure by Type, 2020-2025 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
  • Company Profiles

IVD Test Procedure Volumes, 2020-2025 includes profiles of the top twelve IVD market competitors, looking in detail where possible at procedural volume by type. The companies covered are the following:

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics (Ortho)
  • QIAGEN N.V.
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

The report includes estimates of average fees paid to clinical laboratories and medical establishments for specific groups of IVD procedures. In addition, list prices published by producers are provided for selected IVD tests, reagents, and instruments. A table that measures the total amount of IVD product sales against the total volume of IVD procedures is presented for each major testing category. The IVD market, defined in procedure volume and pricing tables, makes up the market data in this report. Procedure volume estimates are provided for various categories, and average selling price (ASP) for tests are calculated.

Note: Product cover images may vary from those shown

Chapter One: Executive Summary

  • Figure 1-1 Global IVD Procedure Volumes, 2020 and 2025

IVD Procedure Volume Estimate and Forecast
Scope & Methodology

Chapter Two: Introduction

Industry Trends

  • Table 2-1 Global IVD Procedural Volume & Product Sales (excludes glucose tests), 2020-2025

COVID 19

Chapter Three: Healthcare Trends

Overview
Global Macroeconomic Environment
Global Economic Outlook

  • Table 3-1 Gross Domestic Product by Region ($ trillion), 2020-2025

Per Capita Gross Domestic Product

  • Table 3-2 Per Capita GDP ($), 2020-2025

Demographic Trends
Total Population

  • Table 3-3 Population by Region (million persons), 2020-2025

Age Distribution

  • Table 3-4 Population 50 Years & Older by Region (million persons), 2020-2025
  • Table 3-5 Population 65 Years & Older by Region (million persons), 2020-2025

Global Healthcare Trends
Health Expenditures

  • Table 3-6 Health Expenditures by Region ($ billion), 2020-2025

Hospitals

  • Table 3-7 Number of Acute Care Hospitals by Region (thousand), 2020-2025

Physicians

  • Table 3-8 Number of Practicing Physicians by Region (thousands), 2020-2025

Clinical Laboratories
Patient Activity

  • Table 3-9 Number of Hospital Admissions by Region (millions), 2020-2025
  • Table 3-10 Number of Surgical Procedures by Region (millions), 2020-2025
  • Table 3-11 Number of Outpatient Consultations by Region (millions), 2020-2025

Chapter Four: IVD Testing Segments

IVD Testing Trends

  • Table 4-1 IVD Procedural Volume including blood glucose tests (millions), 2020-2025
  • Table 4-2 IVD Procedural Volume excluding blood glucose tests (millions), 2020-2025

Segment Growth Projections
POC Testing
Clinical Chemistry
Immunoassays
Mass Spectrometry (Immuno)
Molecular Assays
Hematology
Coagulation
Conventional Microbiology
Mass Spectrometry (Micro)
Blood Grouping/Matching
Histology/Cytology
COVID 19

  • Table 4-3 IVD Product Sales including blood glucose tests ($ millions), 2020-2025
  • Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2020-2025

Chapter Five: Global IVD Markets

General

  • Table 5-1 IVD Procedural Volume excluding blood glucose tests by Region (millions), 2020-2025
  • Table 5-2 IVD Product Sales excluding blood glucose tests by Region ($ millions), 2020-2025

North America
United States
Canada
Mexico
Central & South America
Brazil
Other Central & South America
Western Europe
France
Germany
Italy
Spain
United Kingdom
Other Western Europe
Eastern Europe
Russia
Other Eastern Europe
Asia/Pacific
China
India
Japan
South Korea
Australia
Other Asia/Pacific
Middle East
Turkey
Other Middle East
Africa

Chapter Six: Point-of-Care (POC) Procedures

Global POC Procedure Volume by Test Type

  • Table 6-1 Total POC Procedural Volume & Product Sales including blood glucose tests, 2020-2025
  • Table 6-2 Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2020-2025

POC Self Tests

  • Table 6-3 POC Self-Test Procedural Volume by Type (millions), 2020-2025

Traditional Blood Glucose Monitoring Activities
Continuous Blood Glucose Monitoring
Fertility Testing
Coagulation Testing
Fecal Occult Blood Testing
Drugs of Abuse Testing
H. Pylori Testing
HIV Testing
Cholesterol Testing
POC Urinalysis Testing
Other POC Self-Testing
POC Self-Testing Product Sales

  • Table 6-4 POC Self-Test Product Sales by Type ($ millions), 2020-2025

Pricing Trends
COVID 19

  • Table 6-5 POC Self-Test $ IVD Product Sales Per Procedure, 2020-2025

POC Professional Testing

  • Table 6-6 POC Professional Procedural Volume by Type (millions), 2020-2025

POC Professional Blood Glucose Testing Procedures
POC Professional Critical Care Testing
POC Fertility Testing
POC Professional Infectious Disease Testing
POC Professional Cardiac Marker Testing
POC Professional Cholesterol/Lipid Testing
POC Professional Coagulation Testing
POC Professional HbA1C Testing
POC Professional Hematology Testing
POC Professional Fecal Occult Blood Screening
POC Professional Drugs of Abuse Testing
POC Professional Urinalysis Testing
Other POC Professional Testing
POC IVD Product Sales

  • Table 6-7 POC Professional IVD Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 6-8 POC Professional $ IVD Products Per Procedure by Type (millions), 2020-2025

Chapter Seven: Clinical Chemistry Procedures

  • Table 7-1 Clinical Chemistry Procedural Volume by Type (millions), 2020-2025

Types of Tests
General Chemistry
Blood Gases & Electrolytes
Urinalysis
Global Sales of Clinical Chemistry Products

  • Table 7-2 Clinical Chemistry Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 7-3 Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2020-2025

Chapter Eight: Immunoassay Procedures

Technologies
Labeling Techniques
Enzyme Immunoassays
Fluorescence Polarization Immunoassays (FPIAs)
Radioimmunoassays (RIAs)
Testing Procedures & Product Sales

  • Table 8-1 Immunoassay Procedural Volume by Type (millions), 2020-2025
  • Table 8-2 Immunoassay Product Sales by Type (millions), 2020-2025

Cardiac Markers
Tumor Markers
Autoimmune Conditions
Allergy Conditions
Thyroid Conditions
Proteins
Anemia
Fertility Testing
Therapeutic Drug Monitoring
Vitamin D
Diabetes/HbA1c
Drugs of Abuse
Infectious Diseases
Blood Screening
Instruments
Pricing Trends

  • Table 8-3 Immunoassay $ Product Sales Per Procedure by Type, 2020-2025

Chapter Nine: Molecular Testing Procedures

  • Table 9-1 Molecular Assay Procedural Volume by Type (millions), 2020-2025

Types of Test
Testing Technologies
Infectious Diseases

  • Table 9-2 Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2020-2025

Blood Screening
Cancer
Transplant Matching
Thrombophilia SNPs
Inherited Diseases
Pharmacodiagnostic Tests
Global Sales of Molecular IVD Products

  • Table 9-3 Molecular Assay Product Sales by Type ($ millions), 2020-2025
  • Table 9-4 Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 9-5 Molecular Assays $ Products per Procedure by Type, 2020-2025

COVID 19

Chapter Ten: Hematology Procedures

  • Table 10-1 Hematology Procedural Volume by Type (millions), 2020-2025

Types of Tests
Global Sales of Hematology Products

  • Table 10-2 Hematology Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 10-3 Hematology $ Product Sales Per Procedure by Type, 2020-2025

Chapter Eleven: Coagulation Testing Procedures

  • Table 11-1 Coagulation Procedural Volume (millions), 2020-2025

Types of Tests
Global Sales of Coagulation Products

  • Table 11-2 Coagulation Product Sales ($ millions), 2020-2025

Pricing Trends

  • Table 11-3 Coagulation $ Products per Procedure, 2020-2025

Chapter Twelve: Microbiology Procedures

  • Table 12-1 Conventional Microbiology Procedural Volume by Type (millions), 2020-2025

Types of Tests
ID/AST Automated Panels & Reagents
Manual Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry
Global Sales of Conventional IVD Microbiology Products
ID/AST Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry

  • Table 12-2 Conventional Microbiology Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 12-3 Conventional Microbiology $ Product Sales Per Procedures by Type, 2020-2025\

Chapter Thirteen: Blood Grouping/Typing Procedures

  • Table 13-1: Blood Grouping/Matching Procedure Volumes ($ millions), 2020-2025

Types of Tests
Blood Grouping/Matching Product Sales

  • Table 13-2 Blood Grouping/Matching Product Sales ($ millions), 2020-2025

Pricing Trends

  • Table 13-3 Blood Grouping/Matching $ Product Sales/Procedure, 2020-2025

Chapter Fourteen: Histology/Cytology Procedures

  • Table 14-1 Histology/Cytology Procedural Volume by Type (millions), 2020-2025

Types of Tests
Pap Tests
In Situ Hybridization Tests
Immunohistochemistry Tests
Traditional Non-Pap Stains
HPV
Circulating Tumor Cells
Histology/Cytology IVD Product Sales

  • Table 14-2 Histology/Cytology Product Sales by Type ($ millions), 2020-2025

Pricing Trends

  • Table 14-3 Histology/Cytology $ Product Sales Per Procedure by Type, 2020-2025

Chapter Fifteen: Company Profiles

  • Table 15-1: Revenues of Selected Top 19 IVD Companies, 2015-2019 ($ million)

Abbott Diagnostics
Recent Revenue History

  • Table: Abbott Diagnostic Revenues 2015-2019 (millions $)
  • Table 15-2: Abbott Diagnostics Global IVD Procedural Volume by Type, 2020 (million)
  • Table: Abbott Diagnostic Revenues 2015-2019 (millions $)

Alere Acquisition Update and Point of Care
Core Lab
Hematology
Blood Banking
Infectious Diseases – Molecular
Diabetes
HIV Point of Care
i-STAT Business
Becton, Dickinson and Company (BD)
Recent Revenue History

  • Table: BD Diagnostic Revenues 2015-2019 (millions $)
  • Table: BD Global IVD Procedural Volume by Type, 2020 (million)
  • Table: BD Revenues in Selected Test Segments 2013, 2019 (millions $)
  • Table: BD Revenues in Flow Cytometry 2015- 2019 (millions $)

Cytology
Molecular Microbiology
Traditional Microbiology – ID/AST
Blood Culture
Hospital Acquired Infections
Connectivity
Blood Collection
Mass Spectrometry
Flow Cytometry
Licensing
COVID-19
bioMérieux Inc.
Recent Revenue History

  • Table: bioMerieux IVD Revenues 2015-2019 (millions $)
  • Table: BD Global IVD Procedural Volume by Type, 2020 (million)
  • Table: bioMerieux Revenues in Selected Test Segments 2015-2019 (millions $)

Traditional Microbiology
Blood Culture
Immunoassays
BioFire Diagnostics Business
COVID-19
Bio-Rad Laboratories, Inc.
Recent Revenue History

  • Table: Bio-Rad Diagnostics Revenues 2015-2019 (millions $)
  • Table: BD Global IVD Procedural Volume by Type, 2020 (million)
  • Table: Bio-Rad Revenues in Selected Test Segments 2015-2019 (millions $)

Blood Bank
Diabetes
Immunoassays
Danaher Corporation

  • Table 15-3 Danaher Global IVD Procedural Volume by Type, 2019 (million)

Hologic, Inc.
Recent Revenue History

  • Table: Hologic Revenues 2015-2019 (millions $)
  • Table: Hologic IVD Procedural Volume by Type, 2020 (million)
  • Table: Bio-Rad Revenues in Selected Test Segments 2015-2019 (millions $)

PANTHER Molecular System
HIV Testing
Sexually Transmitted Infections
Cytology
Ortho Clinical Diagnostics (Ortho)
Recent Revenue History

  • Table: Ortho Clinical Diagnostics Revenues 2015-2019 (millions $)
  • Table: Hologic IVD Procedural Volume by Type, 2020 (million)
  • Table: Ortho Clinical Diagnostics Revenues in Selected Test Segments 2015-2019 (millions $)

Blood Bank
Core Lab / Immunoassays
COVID-19
QIAGEN N.V.
Recent Revenue History

  • Table: QIAGEN N.V. IVD Revenues 2015-2019 (millions $)
  • Table: QIAGEN IVD Procedural Volume by Type, 2020 (million)
  • Table: QIAGEN IVD Revenues by Type, 2020 (million)

Tuberculosis
Molecular Expansion
Precision Medicine / Companion Diagnostics
Molecular Microbiology
Prenatal Testing
Next Generation Sequencing
Sample Prep, Informatics
Digital PCR
Liquid Biopsy
COVID-19
Roche Diagnostics
Recent Revenue History

  • Table: Roche Diagnostics IVD Revenues 2015-2019 (millions $)
  • Table: Roche Diagnostics IVD Procedural Volume by Type, 2020 (million)
  • Table: Roche IVD Revenues by Type, 2015-2019 (million)

Hematology
Core Lab
Immunoassays
Core Molecular
Digital PCR
Diabetes Care
Coagulation
cobas Liat System – POC
HPV
Blood Bank
Cancer Companion Testing
COVID-19
Siemens Healthineers (Siemens)
Recent Revenue History

  • Table: Siemens Healthineers IVD Revenues 2015-2019 (millions $)
  • Table: Siemens Healthineers Diagnostics IVD Procedural Volume by Type, 2020 (million)
  • Table: Siemens IVD Revenues by Type, 2020 (million)

Core Lab
Immunoassays
Hematology
Molecular
Acute Care – POC
COVID-19
Sysmex Corporation
Recent Revenue History

  • Table: Sysmex IVD Revenues 2015-2019 (millions $)
  • Table: Sysmex IVD Procedural Volume by Type, 2020 (million)
  • Table: Sysmex IVD Revenues by Type, 2015-2019 (million)

Hematology
Coagulation
Urinalysis
Immunoassays
Flow Cytometry
Precision Medicine / Companion Test Diagnostics
Oncology
COVID-19
Thermo Fisher Scientific Inc.
Recent Revenue History

  • Table: Thermo Fischer IVD Revenues 2015-2019 (millions $)
  • Table: Siemens Healthineers Diagnostics IVD Procedural Volume by Type, 2020 (million)
  • Table: Roche IVD Revenues by Type, 2016-2019 (million)

Immunoassays
Microbiology
Next Generation Sequencing
qPCR
COVID-19

Note: Product cover images may vary from those shown
Adroll
adroll